Skip to main content

Month: April 2020

Intelligent Systems Schedules First Quarter 2020 Earnings Release and Conference Call

NORCROSS, Ga., April 28, 2020 (GLOBE NEWSWIRE) — Intelligent Systems Corporation [NYSE American: INS, www.intelsys.com], the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor conference call on Tuesday, May 5, 2020 at 11:00 A.M. Eastern Standard Time in conjunction with the company’s earnings release for the quarter ended March 31, 2020. The company plans to issue a press release with the financial results for the period before the market opens on May 5, 2020.

Continue reading

Atlantic Union Bankshares Reports First Quarter Results

RICHMOND, Va., April 28, 2020 (GLOBE NEWSWIRE) — Atlantic Union Bankshares Corporation (the “Company” or “Atlantic Union”) (Nasdaq: AUB) today reported net income of $7.1 million and diluted earnings per share of $0.09 for its first quarter ended March 31, 2020.  Pre-tax pre-provision earnings(1) were $68.3 million, or $0.86 per share(1), in the first quarter ended March 31, 2020.“Atlantic Union began 2020 with momentum and an ambitious set of work ahead of us, but as the situation surrounding the COVID-19 coronavirus pandemic unfolded, we quickly adjusted our thinking,” said John C. Asbury, President and CEO of Atlantic Union.  “We believe that we pivoted smoothly to a new operating model with over 90% of non-branch personnel working remotely, demonstrating we’ve built a resilient organization that can react and innovate rapidly...

Continue reading

Forløb af ordinære generalforsamlinger i Investeringsforeningen BankInvest og Kapitalforeningen BankInvest Select den 28. april 2020

Copenhagen, April 28, 2020 (GLOBE NEWSWIRE) —Ovennævnte foreninger har afholdt ordinære generalforsamlinger tirsdag den 28. april 2020.Sidste dag for handel med de enkelte afdelinger/andelsklasser inklusive ret til aconto-udbytte var den 3. februar 2020. Første dag for handel med de enkelte afdelinger/andelsklasser eksklusiv ret til aconto-udbytte var den 4. februar 2020.Investorerne havde udbyttet til rådighed på depotet den 6. februar 2020.Udbyttebetalingen til investorerne er blevet foretaget aconto og udgjorde 2,2 mia. kr.Foreningernes samlede resultat udgjorde i alt til 8,2 mia. kr.Bestyrelseshonoraret for 2019 blev enstemmigt godkendt.Investeringsforeningen BankInvestDe af bestyrelsen foreslåede generelle samt afdelingsspecifikke vedtægtsændringer blev enstemmigt vedtaget.Kapitalforeningen BankInvest SelectDe af bestyrelsen...

Continue reading

Investors House Oyj:n varsinaisen yhtiökokouksen päätökset

Investors House OyjPörssitiedote, julkaistavissa 28.4.2020 klo 14.30Investors House Oyj:n varsinaisen yhtiökokouksen päätöksetInvestors House Oyj:n varsinainen yhtiökokous päätti vahvistaa yhtiön tilinpäätöksen ja konsernitilinpäätöksen tilikaudelta 1.1.2019 – 31.12.2019.Yhtiökokous päätti jakaa tilikaudelta 2019 osinkoa 0,13 euroa osakkeelta. Osingonmaksun täsmäytyspäivä on 30.4.2020. Osinko maksetaan 8.5.2020 alkaen.Yhtiökokous päätti valtuuttaa hallituksen päättämään enimmillään 0,12 euron osakekohtaisesta lisäosingosta siten, että valtuutus on voimassa 31.12.2020 asti.Yhtiökokous päätti myöntää vastuuvapauden hallituksen jäsenille ja toimitusjohtajalle 31.12.2019 päättyneeltä tilikaudelta.Yhtiökokous päätti hyväksyä yhtiön toimielinten palkitsemispolitiikan.Yhtiökokous päätti, että hallituksen puheenjohtajalle maksetaan vuosipalkkiona...

Continue reading

Forløb af ordinære generalforsamlinger i Investeringsforeningen BankInvest og Kapitalforeningen BankInvest Select den 28. april 2020

Copenhagen, April 28, 2020 (GLOBE NEWSWIRE) —Ovennævnte foreninger har afholdt ordinære generalforsamlinger tirsdag den 28. april 2020.Sidste dag for handel med de enkelte afdelinger/andelsklasser inklusive ret til aconto-udbytte var den 3. februar 2020. Første dag for handel med de enkelte afdelinger/andelsklasser eksklusiv ret til aconto-udbytte var den 4. februar 2020.Investorerne havde udbyttet til rådighed på depotet den 6. februar 2020.Udbyttebetalingen til investorerne er blevet foretaget aconto og udgjorde 2,2 mia. kr.Foreningernes samlede resultat udgjorde i alt til 8,2 mia. kr.Bestyrelseshonoraret for 2019 blev enstemmigt godkendt.Investeringsforeningen BankInvestDe af bestyrelsen foreslåede generelle samt afdelingsspecifikke vedtægtsændringer blev enstemmigt vedtaget.Kapitalforeningen BankInvest SelectDe af bestyrelsen...

Continue reading

Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.

The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split.LOS ANGELES, April 28, 2020 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), is urging its stockholders to vote now on the proposed merger with Qualigen, Inc. (“Qualigen”), a biotechnology company focused on the development of novel therapeutics for the treatment of cancer and infectious disease, as well as the expansion of its flagship FastPack® point-of-care diagnostic platform.“We are urging all of our stockholders to take a few minutes to vote by phone, internet or mail on this important transaction,” said Ritter CEO Andrew J. Ritter. “It’s also important to note that the merger cannot be consummated...

Continue reading

MacroGenics Announces Date of First Quarter 2020 Financial Results Conference Call

Rockville, MD, April 28, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter 2020 after the market closes on Tuesday, May 5, 2020. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Tuesday, May 5, 2020 at 4:30 p.m. ET. The conference call can be accessed by dialing (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes prior to the start of the call and providing the Conference ID 2993147.The listen-only webcast of the conference call can be accessed under “Events & Presentations” in the Investor...

Continue reading

Kiniksa Reports First Quarter 2020 Financial Results and Highlights Recent Corporate and Pipeline Activity

– Financial guidance and clinical timelines for rilonacept, mavrilimumab, vixarelimab and KPL-404 remain intact amid COVID-19 pandemic –– Mavrilimumab treatment protocol in COVID-19 pneumonia and hyperinflammation shows evidence of treatment response in all 13 non-ventilated patients dosed –– Preparing registrational development program of mavrilimumab in patients with COVID-19 pneumonia and hyperinflammation –– Phase 2 trial of vixarelimab in prurigo nodularis met primary efficacy endpoint: statistically significant reduction of weekly average WI-NRS at Week 8 –HAMILTON, Bermuda, April 28, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical...

Continue reading

Primoris Services Corporation Announces Utility Award Valued at $105 Million

DALLAS, April 28, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced the renewal of a Master Service Agreement (“MSA”) with a major utility customer with a three year anticipated value of $105 million. The contract was secured by Q3 Contracting, part of the Utilities & Distribution segment. The award is a three-year agreement for the construction and installation of electric cable and natural gas mains and services in the Western region of the U.S.It is estimated that the MSA will generate approximately $35 million per year over the course of the contract. While the agreement does not obligate the customer to award Primoris a specific dollar amount, our discussions and history with the customer form the basis for our anticipated value.ABOUT PRIMORISFounded...

Continue reading

Corning Reports First-Quarter 2020 Results

CORNING, N.Y. , April 28, 2020 (GLOBE NEWSWIRE) — Corning Incorporated (NYSE: GLW) today announced results for first-quarter 2020.GAAP sales were $2.4 billion; core sales were $2.5 billionGAAP EPS was $(0.16); core EPS was $0.20GAAP net loss was $96 million; core net income was $177 millionThe primary difference between GAAP and core results was non-cash charges related to capacity realignment and cash severance paymentsGiven the economic uncertainty and disruption created by COVID-19, the company is withdrawing its full-year 2020 guidance. In response to the pandemic, the company has been and will continue focusing actions on three core priorities: preserving the financial strength of the company, protecting employees and communities, and delivering on customer commitments.Wendell P. Weeks, chairman and chief executive officer, said:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.